Speakers
Esam Abualrous, Principal Scientist, Schrödinger
Richard Adair, Virology Senior Manager, SGS
Tim Aitman, Director Of Centre For Genomic And Experimental Medicine, University of Edinburgh
Amer-Denis Akkad, Head of Transactional Science, Absci
Felipe Albrecht, Principal Scientist, pRED D&A Governance & Strategy, Roche
Ana Filipa Alexandre, Senior Director, Pipeline Head for Neuroscience, Teva Pharmaceuticals
Juan Carlos Almagro, R&D Director, UDIBI-National Polytechnique Institute
Luis Alvarez-Vallina, H12O-CNIO Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO)
David Auslander, Principal Scientist, Novartis
Ronald Backer, Sr. Field Application Scientist, Luminex Corporation
Baptiste Balbuena, Application Engineer Downstream, Merck Group
Alain Beck, Senior Director, Centre d'Immunologie Pierre Fabre
Philip Beer, Chief Scientific Officer, Step Pharma
Stephen Beers, Professor of Immunology and Immunotherapy, University of Southampton
Jean-François Bellec, Biologics Market Development Manager, Bio-Techne
Nicola Beltraminelli, Chief Development Officer, Head of RED, INNATE PHARMA
Ralph Beneke, Market Specialist for Molecular Biology Research, Agilent Technologies
Romain Bertrand, Director, ADC chemistry, Araris Biotech AG
Martin Bertschinger, Deputy Cell Sciences Director, Ichnos Glenmark Innovation
Oren Beske, Amalgamator of Business and Biology, ATUM BIO
thierry besson, senior scientist II, Novartis
Gina Bicknell, Partner, Pinsent Masons
Simone Bido, Researcher, IRCCS Ospedale San Raffaele
Oliwia Bochenska, Analytical Expert at Development and Contract Testing Department, Selvita
Igor Bogdanoski, Feasibility Manager, Comac Medical
Thomas Bols, Head of Government Affairs and Patient Advocacy, EMEA, PTC Therapeutics
Sara Bonetti, Senior Scientist, Salipro Biotech AB
Louis Boon, Chief Scientific Officer and Board member JJP Biologics, JJP Biologics
Tanima Bose, Senior Principal Scientist, Analytical lead, Novartis
Laure Bouchez, Executive in Residence, General Inception
Frederic Bouder, Professor Of Risk Management, University of Stavanger
Caroline Boulliat, md, Genchrome
Jerome Boyd-Kirkup, Chief Scientific Officer, Hummingbird Bioscience
Diego Braguglia, GP, VI Partners
Julia Braunmüller, Manager Scientific & Technical Affairs, Patheon, Thermo Fisher Scientific
David Brockwell, Professor, University of Leeds
Patrick Brossard, Director Clinical Pharmacology, Sobi (Swedish Orphan Biovitrum)
Valentin Bruttel, CSO, Toleris
Sascha Oliver Buchner, Co-Founder and Partner, Forty51 Ventures AG
Craig Burton, Executive Director, Biosimilars Council
Ursula Busse, Head of Regulatory Affairs, Tigen Pharma SA
Stéphane Busso, Scientist I - Cell Line Development, Fresenius Kabi SwissBioSim
Erica Byerley, Global Senior Tech Transfer Engineer, ThermoFisher Scientific
Michela Castellani-Kleinschroth, Head of MS&T, SKAN AG
Prasun Chakraborty, Founder and Chief Executive Officer, Genevation LTD
Arindam Chakraborty, PhD, General Manager, Enzene Biosciences Ltd
Barry Chester, Director, Pfizer
Andre Choo, Deputy Executive Director, Bioprocessing Technology Institute
Mimi Choon-Quinones, Founder & Board Chairman, Partners For Patients NGO
Michael Chungyoun, Chemical & Biomolecular Engineering, Johns Hopkins University
Rodolfo Ciuffa, Bioinformatics Software Engineer, Alloy Therapeutics
Natalie Coan, Senior Associate, Pinsent Masons
Sam Cooper, Co-Founder, Phenomic AI
Tom Cornell, Protein Engineering Senior Manager, Abzena
Paul Cornes, Oncologist, University Hospitals Bristol N.H.S. Foundation Trust
Elisa Corsiero, Senior Lecturer, William Harvey Research Institute
Silvia Crescioli, Business Intelligence Creator, The Antibody Society
Marc Davies, VP, R&D, Leucid Bio
Tomas de Garay, Product Manager, Refeyn
Carmen De Santo, Cruk New Investigator Fellow, Cancer Research UK
Roberto Di Niro, Associate Director, Project Services, IQVIA Laboratories
Gundo Diedrich, Executive Director, MacroGenics
Nikolay Dobrev, Head of Biology, Epsilico
Patrick Doonan, Director of Antibody Engineering, Ailux
Meghan Drummond, Director, Regeneron Genetic Medicines, Head of Auditory Sciences, Regeneron
Joan D'souza, Consultant, Independent PV Expert
Stefan Dübel, Director, Technical University of Braunschweig
Stefan Duhr, NanoTemper
Lindy Durrant, Joint CEO and CSO, Scancell Ltd
Hilmar Ebersbach, Chief Scientific Officer, Immunos Therapeutics
Jack Elands, CEO, Adcytherix
Dominik Escher, Managing Partner, Pureos Bioventures
Thierry Escudier, Chairman, DCRIPT (Comac Medical Consultant)
Jennifer Eyerman, Clinical Trial Partner, Roche
Séverine Fagète, Vice President, Mammalian Cell Line Services, KBI Biopharma
David Falck, Assistant Professor, Leiden University Medical Center (Netherlands)
Mourad Farouk Rezk, Global Head Of Medical And Development, Biosimilars, biogen
Matthias Feige, Technical University Munich
Nadia Fernandez, Industry Clinical Collaboration Leader, F. Hoffmann-La Roche Ltd.
Maria Fiammetta Romano, Professor, University of Naples Federico II
Gregory Fiore, Former CEO, Exacis Biotherapeutics
Helena Maja Firczuk, Protein Expression Technologies Team Leader, Gsk
Jens A Fischer, Program Manager (Large Molecule Research) for Immunology, Infectious Diseases & Rare Blood Disorders, Roche
Kevin Fitzgerald, Chief Scientific Officer, Epsilogen
Etienne, François, Léo Matous, Senior Principal Scientist and Head of Lead Optimization, Ichnos Glenmark Innovation
Linnea Franssen, Senior M&S Scientist, Roche
Andrea Galbiati, Group Leader, Chemistry, Philochem
Laura Garcia Prat, Scientist, Cimeio Therapeutics
Ettore Gilardoni, Head of Mass Spectrometry, Philochem
John Gill IV, Independent
Adi Goldezweig, CTO, Scala Biodesign
Steffen Goletz, Professor, Department of Biotechnology and Biomedicine, Danish Technical University
Ridhima Gomkale, Platform Development Scientist, LenioBio
Heidi Wei Gong, CMC Operation General Manager, Aton biotech
Dragan Grabulovski, Chief Executive Officer, ARARIS Biotech
Christoph Grapentin, Group Leader Formulation Development, Lonza Group Ltd
Torbjorn Graslund, Professor, K.T.H. Royal Institute of Technology
Ulf Grawunder, Chief Executive Officer & Co-Founder, T-Curx
Sherry Gu, EVP & CTO, WuXi Biologics
Uwe Gudat, Chief Medical Officer, Biocon Biologics
Stefano Gullà, CSO, Kling Biotherapeutics
Prateek Gupta, SVP and Head, Technical Development & MSAT, OneSource Speciality Pharma Limited
Thomas Hach, GPCH, Novartis
Livnat Halel, Experienced Clinical Projects Manager, Independent
Anissa Harbi, Immunologist, Les Hôpitaux d'Alger
Emma Harding, Senior Director, Head of Molecular Design and Engineering, Large Molecule Discovery, Gsk
Luluah Hashim Husain, Global Head of Finance, Biosimilars, biogen
Hooman Hefzi, Associate Professor, Danish Technical University
Katrin Heinrich, Scientist, Roche Diagnostics GmbH
Charlie Heise, Associate Director, Bioprocessing Strategy & Development, FUJIFILM Diosynth Biotechnologies
Tim Heiseler, Senior Application Scientist, Sartorius
Ian Henshaw, Global Head Of Biogen's Biosimilars Unit, biogen
Jana Hersch, Head of Scientific Engagement, Genedata
Youssef Hijazi, Distinguished Scientist Pharmacokinetics, Sanofi-Aventis GmbH Germany
Oliver Hill, Senior Director Protein Engineering, Yumab GmbH
Jeroen hofenk, Founder and CSO, Swiftpharma
Philipp Holliger, Program Leader, M.R.C. Laboratory of Molecular Biology
Liang Hong, Professor, Shanghai Jiao Tong University
Sebastian Hörner, Senior Scientist, BiconY Therapeutics
Maisie Huang, Senior Manager, HuniLife Biotechnology
Thomas Huber, Athebio
Bjoern Hueber, Senior Principal Scientist Data Science, Novartis
Michael Huebner, Director, Country Lead, Johnson & Johnson Innovation
James Humphrey, Research and Technology Specialist, Croda
Dan Hydes, President, IgniteData
Christel Iffland, Senior Vice President, Antibody Technologies, OmniAb Inc
Alejandro Infante, Senior Technologist, Cell Culture Development, Lonza
Melita Irving, Group Leader, University of Lausanne
Peter Jahnmatz, BDD, Salipro Biotech AB
Salma Jalal, Product Marketing Manager, Refeyn
Ruediger Jankowsky, CEO, AATec Medical GmbH
Marc Jarvis, Associate, Patent Attorney, Pinsent Masons LLP
Maciej Jasiński, Director of Biologics, Ardigen
Shashi Jatiani, Director of Research, SeromYx Systems
Rajesh Jayachandran MD PhD, CSO, NXI Therapeutics
Rubin Jiang, Director of antibody process development & MSAT, ProBio
Eloisa Jimenez Nunez, Project Manager Director, Pierre Fabre
Bruno Jolain, Portfolio and Strategy Lead - Health Equity and Population Science, Roche
Peter Jorgensen, Chief Executive Officer, Danish Generic and Biosimilar Medicines Industry Association (IGL)
Stephanie Kapelski, Matrix Lead Screening & Assays, BAYER AG
Sophia Karagiannis, Professor Of Translational Cancer Immunology And Immunotherapy, King's College London
Vijaykumar Karuppiah, Associate Director, Immunocore Ltd
Marc-André Kasper, VP Chemistry and Early Discovery, Tubulis GmbH
Hans Keirstead, Chief Executive Officer, AIVITA Biomedical, Inc.
Hans Keirstead, Chairman, Immunis Inc.
Hans Keirstead, CEO, The Human Immunome Project
Karan Khambati, Global Portfolio Expansion Director, Abbott
Sridevi Khambhampaty, CEO, Shilpa Biologicals Pvt Ltd
Manish Khatri, Director, Clinical Science Data & AI Lead, Clinical Development, Novartis
Divor Kiseljak, Chief Operating Officer, Excellgene
Christian Klein, Dept Head, Roche Pharmaceutical Research and Early Development
Friedrich Koch-Nolte, Professor, University Medical Center Hamburg-Eppendorf
Isabel Kolinko, Digital Transformation and Data Analytics Manager, Genedata
Dmitrij Kollins, Clinical Development Medical Director, Novartis
Harald Kolmar, Head of Department Applied Biochemistry, TU Darmstadt Biochemie
Bertolt Kreft, CSO, Bright Peak Therapeutics AG
Peter Kristensen, Professor, Aalborg University
Dan Bach Kristensen, Scientific Director, Symphogen
Anil Kumar, Head of CMC, Europe, ACROBiosystems
David Laine, Director of Antibody Generation, Teva Pharmaceuticals
Vincent Larraillet, Senior Scientist, Roche
Mayra Latorre-Martinez, Clinical Study Assessor, Swissmedic
Heinz Läubli, Group Leader, Head of Clinical Research Oncology, University Hospital Basel
Amélie Laurendon, Principal Scientist, Ichnos Glenmark Innovation
Victor Le, Scientist, Novartis
Nicolas Lebesgue, Principal Scientist, Novartis Pharma AG
Gabrielle Leclercq, Senior Scientist, Roche Glycart
Steve Lehrer, MD, SBLehrer LLC
Justyna Leja-Jarblad, Head of Clinical Development, Lokon Pharma
Jimmy Li, CEO, WuXi XDC
Giuseppe Licari, Lead Scientist Computational Structural Biology, Merck KGaA Darmstadt Germany
Lars Linden, Head Biologics Research, BAYER AG
Britta Lipinski, PhD Candidate – Antibody Discovery and Protein Engineering, Merck Healthcare KGaA
Pasquale Lombardi, Clinical Fellow, Imperial College London
Margaux Longuespee, Project Manager Quality, EYLIO
Rémi Longuespée, Mass Spectrometry Expert, Novalix
Robin Loving, CSO, Salipro Biotech AB
Maria Lteif, phD student, Paris Saclay University
Luciano Lucas, Senior Director AI Product & Imaging Innovation, Leica Microsystems
Narendra Maharaj, Head- Clinical Development, Biologics, Dr Reddys Laboratories Limited
Bernard Maillere, Head of laboratory, CEA
Magdalena Malm, Lab Manager / Research Scientist, Royal Institute of Technology
Martina Marauli, Director Clinical Supply Innovation, MSD Innovation & Development GmbH
Julie Maréchal-Jamil, Director Biosimilars Policy & Science, Medicines for Europe
Marisca Marian, Access Strategy Lead, Bayer
Andrea Marschall, Postdoctoral, Technical University of Braunschweig
Aimee Mattei, Director of Bioinformatics, EpiVax Inc
Alessandro Mazzetti, Head, Innovation and Entrepreneurship / Deputy Managing Director, University of Basel
John Mccafferty, Founder and Chief Technology Officer, Maxion Therapeutics
Pamela McLaughlin, Clinical Trial Manager and Clinical Chemist, PhD, University Hospital Basel
Raj Mehta, CEO, Adendra Therapeutics
Clive Metcalfe, Principal Scientist Monoclonal Antibodies, MHRA
Salah M-Glueer, Co-Founder and Director of Research and Development, PeriCard Check GmbH
Erich Michel, Senior Researcher, University of Zurich
Cléa Michel, Product Management Director, Evonik
Enkelejda Miho, Dean and Professor, University of Applied Sciences Northwestern Switzerland
DR MICHEL MIKHAIL, Expert in Global Regulatory Affairs and Governmental relations, Expert in Biosimilars, Independent
Kris Modig, FAS, PipeBio
Lorenzo Montrasio, Member of Volrethics Steering Committee, Former Council of Europe
Gustavo Moreira, Head of Antibody and Protein Biochemistry, Tacalyx
Aurore Morello, Head of Research, Director of R&D, O.S.E. Immunotherapeutics
Lotte Mousset, Scientist, LAVA Therapeutics
Andre Mueller, Marketing Manager, Biologics Solutions, Unchained Labs
Michael Muenzberg, Business Development Officer, Rotterdam Biologics B.V.
Marius Müller, Team Lead Analytical Fill-Finish Support, Janssen
Matthias Müllner, CEO, bespark*bio
Dario Neri, Professor of ETH and CEO of Philogen, Swiss Federal Institute of Technology Zurich
Sarfaraz Niazi, PROFESSOR, University of Illinois
Francesca Nice, Senior Scientist, Alchemab Therapeutics Ltd
Cecil Nick, Vice President (Technical), Parexel
Björn Niebel, Senior Principal Scientist, Sanofi Ghent - Sanofi R&D
Ahuva Nissim, Professor, Queen Mary University
Petr Obrdlik, Associate Director, Novartis
Peter O'Callaghan, Senior Director, Licensing, Lonza Biologics
David O'Connell, Associate Professor, School Of Biomolecular And Biomedical Science, University College Dublin
Sebastian Oehler, Senior Scientist, Philochem
Aline Oliveira, Competitive Intelligence Analyst, Institute of Technology on Immunobiologicals (Bio-Manguinhos)
Wayne Paes, Senior Scientist, Grey Wolf Therapeutics
Aniko Palfi, Director Biochemistry & Cell Biology, Heidelberg Pharma
Joseph PARK, Senior Manager, Samsung Bioepis
Samantha Paston, Head of Translational Research, Scancell Ltd
Romain Pastor, Associate director, Novartis
Yash Patel, Product Specialist CLD, Sartorius
Thirupathi Pattipaka, Director, Advanced Analytics, Novartis
Lewis Penny, Principal Scientist (Fluid Biomarkers), Taurx Therapeutics Ltd
Mario Pereira, Director of Technology and Business Development., ATUM
Isabelle Petit-Topin, Team/Lab Lead in Downstream Process _ Manufacturing Science and Technology (DSP MS and T), Novartis France
Douglas Phillips, Senior Scientist Antibody Discovery, Mabylon AG
Andreas Plueckthun, Professor Of Biochemistry, Director, Department Of Biochemistry, University of Zurich
Simon Plyte, CSO, Biomunex Pharmaceuticals
Philipp Probst, Director ADC Research, Araris Biotech AG
Léa Proulx, Patient Voice Partner, Roche
Steve Quayle, VP Research Biology & Translational Medicine, CUE Biopharma
Andy Racher, Director of Commercial Operations, SYNGENSYS
Moutih Rafei, Full Professor, University of Montreal
Alexander Rau, Scientist Protein Engineering, Anaveon
Katharina Reefschläger, Technical Sales Specialist Custom Antibodies, Bio-Rad
Andreas Reimann, Principal Scientist, Ichnos Glenmark Innovation
Nathan Riguet, Senior Investigator, Ichnos Glenmark Innovation
Pramila Rijal, Career Development Fellow, University of Oxford
Tracey Roberts, Partner, UPC Representative, Pinsent Masons
Johan Rockberg, Professor, KTH
Natalia Rodrigues Mantuano, Project Leader, University Hospital of Basel
CHRISTINE ROTHE, Chief Development Officer, iOmx Therapeutics AG
Giulio Russo, Senior Scientist, Merus
Nicolas Sabarth, Research Laboratory Head in Biotherapeutics Discovery and Cancer Immunology, boehringer-ingelheim
Anguraj Sadanandam, Team Leader, Institute of Cancer Research
Sreedhar Sagi, Head, Medical Affairs International Region, Sandoz
Ulisse Salazar, PhD Candidate, University of Zurich
Rainel Sanchez de la Rosa, Executive Director Medical Affairs Europe, Astellas Gene Therapy
Paul Sauter, Director Chemistry & Bioconjugation, Veraxa Biotech Gmbh
Adrien Schmid, Senior Manager, CSL Behring AG
Simone Schmitt, VP Technology and Operations, Memo Therapeutics AG
Jan Schnitzer, CEO, P.R.I.S.M.
Fabian Schuette, Commercial Business Development Manager, Gerresheimer
Felix Schumacher, Program Leader, Targeted Therapeutics, Roche
El-houcine Sebbar, Professor MD PhD, Faculté de médecine et de pharmacie d'Oujda, Université Mohammed Premier d'Oujda
James Seed, Founder and Managing Director, Impact Medical Education
Monique Seymour, Senior Scientific Sales Executive, Rapid Novor Inc
Caibin Sheng, senior scientist, GV20 Therapeutics
Lei Shi, Senior Vice President, Biointron Biological
Elena Shvets, Group Leader, Sphere Fluidics
Oliver Siefert, Senior Scientist, University of Stuttgart
Tomasz Sitar, Head of CMC at JJP Biologics, JJP Biologics
Dr. Sun Chau Siu, Executive Director, Head of Global Regulatory Affairs, Altruist Biologics
Jeremy Skillington, CEO, Poolbeg Pharma plc
Justyna Śladowska, Senior Team Leader at Biological Assays Laboratory, Selvita
Jae Sly, Chief Business Development Officer, Obatala Sciences
Jiri Smejkal, Global Head of Pricing and Tender Excellence for PDT, Takeda
Carsten Soenksen, Scientific Account Manager, Genedata
Andreu Soldevila, Chief Executive Officer, SYNA therapeutics
Evelyn Sollner, Project Manager, Purification Development, Lonza
Colby Souders, Chief Scientific Officer, Biopharma, Twist Bioscience
Frank Staal, Professor of Molecular Stem Cell Biology, Leiden University Medical Center (Netherlands)
Nathalie Steinhoff, Group Leader Pharm/Tox, Numab Therapeutics AG
Andreas Stengl, Team Lead, Protein Engineering, Ludwig Maximilians University Munich
Lars Stöckl, Division Manager, FyoniBio GmbH
Manhee Suh, CTO, Kactus
Mariam Sultani, Director, Global Supply Operations, Pfizer (Seagen)
Mats Sundgren, Senior Industry Scientific Director, i-hd (The European Institute for Innovation through Health Data)
Joseph Taft, Senior Scientist, Engimmune
Oya Tagit, Professor, Head of the Group BioInterfaces, University of Applied Sciences Northwestern Switzerland
Jian Tang, Associate Professor, H.E.C. Montreal
Cuong Tang, Scientific Business Analyst, Sapio Sciences
Lorenz Tanner, Member of Patient Board, SAKK Swiss Group for Clinical Cancer Research
Nazanin Tatari, Post-Doctoral Fellow, University Hospital Basel
Stefanos Theoharis, Chief Executive Officer, OneChain Immunotherapeutics
Michael Thiele, Founder and Chief Scientific Officer, OncoOne Research & Development GmbH
Bert Thomas, Senior Vice President Of Business Development, Bio-Thera Solutions
LAURENT THOUVAIS, Sr Director, D&M BD, PCI Pharma Services
JAKUB TOMALA, Assistant Research Professor, John Hopkins University
Stephanie Traub, Associate Director, UCB
Marco Traub, Chief Executive Officer, TESCT - The Trans European Stem Cell Therapy Society
Gareth Tucker, Commercial Director, Impact Medical Education
Matthew Turner, Government affairs and Biosimilar Policy expert, Independant
Mikko Turunen, Chief Scientific Officer, RNatives
Jens Twellmeyer, Associate Director Science & Technology, Novartis AG
Laura Unmuth, PhD candidate - Early Protein Supply & Characterization, Merck KGaA
Feruza Ushurova, Clinical trial manager, SWISS GO Trial Group
Mart Ustav, CSO, Icosagen Therapeutics
Alain Vertes, Managing Director, NxR Biotechnologies GmbH
Pieter Voermans, Head Clinical Data Management, Sobi
Annette Vogl, VP, Biology and Translational Research, Tubulis GmbH
Ilona Vollrath, Senior Scientist, Roche
Meenu Wadhwa, Section Head, MHRA
Koen Wagner, Senior Scientist for Antibody Engineering and Protein Chemistry, Merus
Theodora Weisz, Head of Patient Advocacy and Public Affairs, Novartis Gene Therapies, Novartis Gene Therapies
Ann White, Senior Director of Translational Science, Mestag Therapeutics
Jörg Wischhusen, Professor, Universitätsklinikum Würzburg
Uwe Wittenberg, Digital Data & IT Business Partner Pre-Clinical Research, Merck Healthcare KGaA, Darmstadt, Germany
Frederick Wittke, Vaccines Clinical Development Team Lead Europe, Independent
Gillian Woollett, VP, Head Regulatory Strategy and Policy, Samsung Bioepis
Rebecca XICLUNA, Senior Scientist, F.Hoffmann-La Roche LTD
Haoheng (Sandy) Yan, Head of US Regulatory Affairs, Shanghai Henlius Biotech Co., Ltd.
Desislava Yanakieva, Lab Head - Antibody Discovery and Engineering & Cell Assay Development, Merck KGaA
Che Yang, Specialist, Novo Nordisk
Voot Yin, Principal Scientist, The Jackson Laboratory
Yi-Ru Yu, Senior Scientist, Pilatus Biosciences SA
michael zaiac, Head of Medical Affairs Oncology Europe and Canada, Daiichi Sankyo
Jiyong Zhang, Chief Business Officer, Nona Biosciences
Alla Zilberman, Vice President, Technical Marketing, Cygnus Technologies Inc
Iwan Zimmermann, Chief Operating Officer, Linkster Therapeutics AG
Michela Zuccolo, Gene Therapy and Rare Strategy, Roche
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events